STOCK TITAN

Global Innovative Platfom (GIPL) Financials

GIPL OTC
FY2025 annual
Revenue $0 n/m YoY
Net Income -$718K YoY not available
EPS (Diluted) -$0.02 n/m YoY
Operating Cash Flow -$561K YoY not available
Market Cap $17K as of Oct 30, 2026
Price / Sales n/m revenue is not positive, FY2025
Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026
Price / Book 0.0x on $531K equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 30, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Jun 30, 2026 Reported Currency USD FYE September

Newest figures come from the 10-Q for Q3 FY2026, filed Aug 14, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the GIPL SEC filings page.

Global Innovative Platfom (GIPL) reported $0 in revenue for fiscal year 2025. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GIPL FY2025

FY2025 shows an expense-funded operation, with losses and investment outflows financed largely through external funding.

Compared with FY2022, the current ratio moved from 0.4x to 17.2x as current assets now exceed current liabilities by a wide margin. That change coincided with liabilities falling 91.1% while assets grew 317.3%, so the improvement reflects balance-sheet change rather than demonstrated operating scale.

FY2025 reported an operating loss of $718K and operating cash flow of -$561K; the gap means accounting expense exceeded cash outflow, so earnings and cash do not move one-for-one.

R&D and SG&A together accounted for the entire FY2025 operating loss, showing spending was concentrated in development and overhead rather than supported by disclosed sales. Investing cash flow was -$175K while financing cash flow was $754K, making external financing the largest disclosed cash source alongside the loss-making operation.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Financial health score not available

We do not publish a peer-relative financial health score for Global Innovative Platfom, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.

Piotroski F-Score Partial
2/6

Global Innovative Platfom passes 2 of 6 computable financial strength tests (3 of the nine could not be computed from available data). 1 of 3 profitability signals pass, 1 of 2 leverage/liquidity signals pass, the one computable operating efficiency signal (asset turnover improving) does not pass.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$51K
YoYn/m
QoQ-52.4%

Global Innovative Platfom generated $51K in revenue in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. Against the prior quarter it is down 52.4%.

EBITDA
-$230K
YoYn/m
QoQn/m

Global Innovative Platfom's EBITDA was -$230K in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

Net Income
-$242K
YoYn/m
QoQn/m

Global Innovative Platfom reported a net loss of $242K in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.

EPS (Diluted)

Not reported for Q3 2026.

Cash & Balance Sheet

Free Cash Flow
-$189K
YoYn/m

Global Innovative Platfom recorded an outflow of $189K in free cash flow in Q3 2026, representing a cash shortfall after capex. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Cash & Debt
$244K
YoY+23.3%
QoQ-25.4%
5Y CAGR+67.5%

Global Innovative Platfom held $244K in cash as of Q3 2026; no long-term debt figure is on record for that period.

Shares Outstanding
50M
YoY+17.9%
QoQ+1.3%

Global Innovative Platfom had 50M shares outstanding in Q3 2026. This represents an increase of 17.9% from the same quarter a year earlier. Against the prior quarter it is up 1.3%.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Return on Equity
-45.5%
YoY+71.3pp
QoQ-19.8pp

Global Innovative Platfom's quarterly ROE was -45.5% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 71.3 percentage points from the same quarter a year earlier. Against the prior quarter it is down 19.8 percentage points.

Gross Margin

Not reported for Q3 2026.

Operating Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for Q3 2026: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending
$3K
YoY-62.3%
QoQ+85.2%

Global Innovative Platfom invested $3K in research and development in Q3 2026. This represents a decrease of 62.3% from the same quarter a year earlier. Against the prior quarter it is up 85.2%.

Capital Expenditures
$55K
YoYn/m

Global Innovative Platfom invested $55K in capex in Q3 2026, funding long-term assets and infrastructure. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Share Buybacks

Not reported for Q3 2026.

GIPL Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GIPL quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$51Kn/m$107Kn/m$30KN/A$0n/m$0n/mN/AN/A
R&D Expenses$3K-62.3%$2K-48.5%$11K-68.8%N/A$9K$4K$34KN/A
SG&A ExpensesN/AN/A$69K-20.3%N/A$212K+3230.5%$151K$86KN/A
Operating Income-$242Kn/m-$151Kn/m-$49Kn/m-$235K-$212Kn/m-$151K-$120KN/A
EBITDA-$230Kn/m-$138K-$44KN/A-$212KN/AN/AN/A
Income Tax$0n/m$0n/mN/AN/A$0n/m$0n/mN/AN/A
Net Income-$242Kn/m-$151Kn/m-$49Kn/m-$235K-$212Kn/m-$151K-$120KN/A
EPS (Basic)-$0.01n/m$0.00n/m$0.00n/m-$0.01n/m-$0.01n/m$0.00n/m$0.00n/m-$0.01n/m
EPS (Diluted)N/AN/A$0.00n/m-$0.01n/m-$0.01n/m$0.00n/m$0.00n/m-$0.01n/m
Diluted Shares (Avg)0n/m0n/m45M+24.6%N/A0-100.0%0-100.0%36M+73.2%N/A

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, Interest Expense.

GIPL Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GIPL quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$539K+157.8%$592K+254.6%$225K+51.5%$199K+1328400.0%$209K+1961.5%$167K+27908.7%$148K+8710.6%$15-96.4%
Current Assets$271K+29.4%$367K+119.6%$55K-63.3%$199K+1328400.0%$209K+1961.5%$167K+27908.7%$148K+8710.6%$15-96.4%
Cash & Equivalents$244K+23.3%$327K+109.9%$49K-67.0%$18K+118753.3%$198K+1852.9%$156K+26059.2%$148K+8710.6%$15-96.4%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Accounts Receivable$15K$18KN/A$0N/AN/AN/AN/A
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Liabilities$8K-72.0%$2K-29.3%$66K+356.6%$12K-65.0%$28K-87.2%$3K-98.4%$14K-92.7%$33K-90.9%
Current Liabilities$8K-72.0%$2K-29.3%$66K+356.6%$12K-65.0%$28K-87.2%$3K-98.4%$14K-92.7%$33K-90.9%
Non-Current Liabilities$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Total Equity$531K+193.1%$590K+260.2%$160K+19.0%$188Kn/m$181Kn/m$164Kn/m$134Kn/m-$33Kn/m
Retained Earnings-$1.7Mn/m-$1.5Mn/m-$1.3Mn/m-$1.3Mn/m-$1.0Mn/m-$809Kn/m-$658Kn/m-$537Kn/m

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

GIPL Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GIPL quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow-$134Kn/m-$149Kn/m$13Kn/m-$65K-$184Kn/m-$174Kn/m-$138KN/A
Depreciation & Amortization$12Kn/m$13K$5KN/A$0N/AN/AN/A
Capital Expenditures$55Kn/mN/AN/AN/A$0N/AN/AN/A
Free Cash Flow-$189Kn/mN/AN/AN/A-$184KN/AN/AN/A
Investing Cash Flow-$55Kn/mN/AN/A-$175Kn/m$0n/mN/AN/A$0n/m
Financing Cash Flow$106K-53.4%$496K+174.0%$19K-93.5%$60K$227K+2167.3%$181K+11966.6%$287KN/A

Not reported in any period shown, so not listed: Stock-Based Compensation, Dividends Paid, Share Buybacks.

GIPL Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

GIPL quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Margin-476.6%-142.2%-164.8%N/AN/AN/AN/AN/A
Net Margin-476.6%-142.2%-164.8%N/AN/AN/AN/AN/A
Return on Equity-45.5%+71.3pp-25.7%+66.8pp-31.0%+58.9pp-125.0%-116.8%-92.5%-89.9%N/A
Return on Assets-44.8%+56.5pp-25.6%+65.1pp-22.0%+59.2pp-117.7%-101.3%-38.6pp-90.7%-81.1%N/A
Current Ratio34.73+27.2x160.49+108.8x0.83-9.5x17.17+17.2x7.52+7.5x51.70+51.7x10.30+10.3x0.000.0x
Liabilities-to-Equity0.01-0.1x0.000.0x0.41+0.3x0.060.150.020.11N/A
Asset Turnover0.09+0.1x0.18+0.2x0.13N/A0.000.0x0.000.0xN/AN/A
FCF Margin-372.2%N/AN/AN/AN/AN/AN/AN/A

Not reported in any period shown, so not listed: Gross Margin, Debt-to-Equity.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Global Innovative Platfom GIPL FY2025 $0 -$718K N/A $17K —
Trex Acquisition Corp TRXA FY2025 $32K -$2.5M N/A $15.7M —

Frequently Asked Questions

Global Innovative Platfom (GIPL) reported $0 in total revenue for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

No, Global Innovative Platfom (GIPL) reported a net loss of $718K in fiscal year 2025.

Global Innovative Platfom (GIPL) reported diluted earnings per share of -$0.02 for fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Global Innovative Platfom (GIPL) has a return on equity of -382.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Global Innovative Platfom (GIPL) recorded an outflow of $561K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

Global Innovative Platfom (GIPL) had $199K in total assets as of fiscal year 2025, including both current and long-term assets.

Global Innovative Platfom (GIPL) invested $383K in research and development during fiscal year 2025.

Global Innovative Platfom (GIPL) had 47M shares outstanding as of fiscal year 2025.

Global Innovative Platfom (GIPL) had a current ratio of 17.17 as of fiscal year 2025, which is generally considered healthy.

Global Innovative Platfom (GIPL) had a liabilities-to-equity ratio of 0.06 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity. No debt-to-equity ratio is shown for fiscal year 2025, because the filing data we hold for that year carries no long-term debt figure.

Global Innovative Platfom (GIPL) had a return on assets of -360.4% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Global Innovative Platfom (GIPL) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $17K as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Global Innovative Platfom (GIPL) has no price-to-sales ratio at the moment: revenue is not positive (FY2025). The market capitalization is $17K as of Oct 30, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Global Innovative Platfom (GIPL) has a Piotroski F-Score of 2 out of 6 computable signals; 3 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Back to top